CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem ® (invimestrocel) for critical care ...
The latest update is out from GeoVax Labs ( (GOVX)). On March 31, 2026, GeoVax Labs entered into a warrant inducement agreement with existing healthcare-focused institutional investors, who agreed to ...
Liquidity risk refers to the marketability of an investment and whether it can be bought or sold quickly enough to meet debt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results